Search / Trial NCT06223230

Nutritional Psychological Intervention and Vomit-free Management on Survival and Quality of Life in Advanced Gastrointestinal Tumors

Launched by RENMIN HOSPITAL OF WUHAN UNIVERSITY · Jan 16, 2024

Apply for Trial

Trial Information

Current as of December 21, 2024

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how certain supportive treatments, specifically nutritional and psychological interventions, can help improve the survival and quality of life for patients with advanced gastrointestinal cancers, such as esophageal, gastric, liver, pancreatic, and colorectal cancers. The trial compares two groups: one that receives standard cancer treatment along with these supportive interventions, and another that only receives standard treatment. The goal is to see if these additional supportive measures can help patients feel better and live longer.

To participate in the trial, individuals need to be between the ages of 18 and 75 and diagnosed with advanced gastrointestinal cancer. They should be expected to live for at least 8 more weeks and be able to attend regular follow-ups. Participants will need to sign a consent form agreeing to join the study. Those with serious health issues unrelated to their cancer, a history of mental illness before their diagnosis, or other specific exclusions may not be eligible. If you or a loved one are considering joining this trial, you can expect to receive both standard cancer treatment and additional support aimed at enhancing your overall well-being.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • 1. Age 18-75, male or female;
  • • 2. Patients with advanced esophageal cancer, gastric cancer, liver cancer and colorectal cancer and other gastrointestinal tumors diagnosed by pathological histology or cytology;
  • • 3. Expected survival ³ 8 weeks and able to receive long-term follow-up;
  • • 4. Eastern Cooperative Oncology Group(ECOG)-Performance Status(PS) score of 0-2;
  • • 5. First-line treatment receiving standard oncology treatment and nutritional psychological intervention and vomit-free management group (study group); first-line treatment receiving only standard oncology treatment group (control group);
  • • 6. Voluntarily signing an informed consent form.
  • Exclusion Criteria:
  • • 1. Other malignant tumors diagnosed within the previous 5 years, except for effectively treated basal cell carcinoma of the skin, squamous cell carcinoma of the skin, or effectively resected in situ cervical cancer or breast cancer;
  • • 2. history of psychiatric illness prior to the diagnosis of the tumor
  • • 3. patients who resist treatment
  • • 4. patients with poorly controlled severe heart disease, liver or kidney insufficiency, severe anemia, multiple lymph node enlargement, leukopenia, etc;
  • • 5. patients who are pregnant or have a pregnancy plan;
  • • 6. patients who, in the judgment of the investigator, are not suitable for inclusion in this study.

About Renmin Hospital Of Wuhan University

Renmin Hospital of Wuhan University is a leading healthcare institution in China, renowned for its commitment to advancing medical research and clinical innovation. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise in various medical fields to facilitate cutting-edge studies aimed at improving patient outcomes and healthcare practices. With a strong emphasis on ethical standards and patient safety, Renmin Hospital collaborates with various stakeholders to drive forward-thinking research initiatives that contribute to the global medical community. Its state-of-the-art facilities and multidisciplinary teams enable efficient trial execution, ensuring robust data collection and analysis in pursuit of transformative healthcare solutions.

Locations

Wuhan, Hubei, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0